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E D I TO R I A L
Implementation of a microsurgical breast reconstruction
program in Mexico
Breast cancer is the most common malignancy in Latin America and in
Mexico (Chávarri-Guerra et al., 2012; Reynoso-Noveron et al., 2017),
and providing multidisciplinary care for patients with breast cancer
represents a major challenge for healthcare systems throughout the
region (Chávarri-Guerra et al., 2012; Reynoso-Noveron et al., 2017).
Since 2007, the Mexican government, through the Seguro Popular
insurance system, has provided coverage for breast cancer treatment
(Chávarri-Guerra et al., 2012;Consejo de Salubridad General, 2011;
Reynoso-Noveron et al., 2017). Unfortunately, Seguro Popular does
not cover other interventions, such as reconstructive surgery (Consejo
de Salubridad General, 2011; Reynoso-Noveron et al., 2017). The
National Cancer Institute of Mexico (INCan) provides care under
Seguro Popular coverage, and although breast reconstruction was
available, its cost had to be covered out-of-pocket until 2012, when a
federal government grant helped establish the Post-Mastectomy Pro-
gram (PMP), aimed at providing free reconstruction (Cuenta De La
Hacienda Pública Federal, 2013). Here, we describe the implementa-
tion of a breast reconstructive microsurgery program at INCan, with
the intent of fostering the development of similar programs in other
low-and-middle-income countries (LMIC).
Before PMP, most patients were treated with tissue expanders
and implants, while others received reconstruction using myocuta-
neous flaps, with approximately 40 reconstructions performed yearly.
With the establishment of PMP, we have progressively built the
capacity to perform microsurgical reconstruction with deep inferior
epigastric perforator (DIEP) flaps in addition to implant-based recon-
struction. Objectives of the microsurgical reconstruction program are
summarized in Figure 1.
All newly diagnosed patients with breast cancer, as well as those
with nonmalignant diseases who are candidates for reconstruction,
are discussed by a multidisciplinary team including plastic surgeons.
Patients desiring reconstruction are evaluated by anesthesiologists
and undergo an abdominal tomography to visualize the deep inferior
epigastric artery. DIEP flap candidates are evaluated by a plastic sur-
geon who explains the procedure and its complications, including
planned number of inpatient days, length, expected cosmetic results,
postoperative care, and potential need for further interventions.
Patients complete the Spanish version of the BREAST-Q™ (Memorial
Sloan-Kettering Cancer Center and The University of British Colum-
bia©) quality of life questionnaire. Microsurgical procedures are per-
formed by a plastic surgeon with microsurgery training and a
microsurgery fellow using a Carl Zeiss Pentero® microscope. Data on
ischemia time, time for surgical anastomosis, and vessel anatomy is
recorded for each procedure.
In 2012, only 6 microsurgical reconstructions were performed at
INCan. From January 2013 to December 2017, 161 microsurgical
reconstructions have been performed, going from 23 in 2013 to 34 in
2017. In 160 cases DIEP flaps were performed, while in 1 case
another technique was utilized (gluteal artery perforator flap). Patient
and surgical characteristics are outlined in Table 1.
Capacity-building is fundamental to our program. Twenty-three
surgeons from Spanish-speaking nations have been trained in recon-
structive breast microsurgery (Figure 2): 10 from Mexico; 5 from
Colombia; 5 from Argentina; and 3 from Spain. Two fellows from
countries outside the Ibero-American region (United States and Italy)
have also been trained. In 2019, the first Central American fellow
(Costa Rica) will complete training. Additionally, we offer a 2-week
course targeted toward plastic surgeons wanting to obtain or enhance
their microsurgical skills.
In Latin America, most patients with breast cancer present with
advanced disease, and up to 80% of women are treated with
FIGURE 1 Objectives of the microsurgical breast reconstruction
program at INCan
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mastectomy (Chávarri-Guerra et al., 2012; Di Sibio, Abriata, Forman, &
Sierra, 2016). This means that most breast cancer survivors in the
region are candidates for reconstruction, which unfortunately is not
covered by most healthcare systems. Although in settings with basic
resources, surgical care should focus on providing curative-intent sur-
gery, upper-middle income countries should strive to provide breast
reconstruction in order to improve quality of care (Anderson
et al., 2008).
Little is known about the status of both breast reconstruction and
microsurgery in Latin America. A survey conducted among plastic sur-
geons in Argentina showed that most respondents performed less
than 25 breast reconstructions per year, of which 80% were implant-
based (Mayer, de Belaustegui, & Loustau, 2018). Another study from
Brazil reported that only 3,161 of the 10,831 women undergoing mas-
tectomy in 2014 received reconstruction, despite the availability of
coverage within the public healthcare system (Freitas-Júnior
et al., 2017).
As part of our future plans, we intend to influence policy makers
into including reconstructive surgery into the care of patients with
breast cancer in Seguro Popular, to analyze the complication rates
and outcomes of patients living in resource-limited settings after
reconstruction, and to test the cost-effectiveness of our microsurgi-
cal program compared with implant-based reconstructions. Addition-
ally, we are building a network of former fellows as a starting point
for future collaborations to study microsurgical breast reconstruction
in LMIC.
Our experience implementing a microsurgical breast reconstruc-
tion program at a public cancer center in a LMIC showcases a self-sus-
tainable, publicly funded multidisciplinary project, and we believe it
can serve as a blueprint for other institutions. Programs like ours, in
TABLE 1 Characteristics of patients undergoing microsurgical breast
reconstruction at INCan between 2013 and 2017
Characteristics N (161) %
Median age, years (range) 45 (21–66)
Body mass index, median (range) 26.8 (18.2–39)
Educational level
None 3 1.9
Elementary school 26 16.1
Middle school 63 39.1
High school/technical 37 23.0
College 32 19.9
Year of reconstruction
2013 23 14.3
2014 31 19.3
2015 32 19.9
2016 41 25.5
2017 34 21.0
Smoking status
Never smoker 133 82.6
Former smoker 15 9.3
Current smoker 13 8.1
Diabetes 4 2.5
Hypertension 16 9.9
Rheumatic diseases 4 2.5
American Society of Anesthesiologists risk category
0 1 0.6
1 110 68.3
2 50 31.1
Previous abdominal scars 105 66.5
Reason for reconstruction
Invasive breast cancer 111 68.9
Ductal carcinoma in situ 19 11.8
BRCA mutation 9 5.6
Phyllodes tumor 8 5.0
Patient preference 8 5.0
Breast sarcoma 4 2.5
Xanthogranulomatous mastitis 2 1.2
Invasive breast cancer stage (N = 109)
IA 23 20.9
IB 1 0.9
IIA 38 34.5
IIB 25 22.7
IIIA 13 11.8
IIIB 6 5.5
IIIC 3 2.7
Received neoadjuvant chemotherapy 34 21.7
Received adjuvant chemotherapy 51 31.7
Received adjuvant radiotherapy 47 29.2
Timing of reconstruction
Immediate unilateral DIEP 89 55.1
Immediate bilateral DIEP 35 21.5
Late DIEP reconstruction 36 22.4
Median days in hospital (range) 6 (2–17)
Perioperative complications requiring
reoperation
42 26.1
Partial/total flap loss 21 13.0
FIGURE 2 Geographical origin of microsurgical fellows trained at
INCan across Ibero-American countries
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which physicians from LMIC learn from each other, are fundamental
for global surgery.
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